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Abstract The sputum smear-negative patients have been a diagnostic challenge for health professionals. Adenosine
deaminase (ADA) activityhas been shownto rise in various body fluids of patientswithtuberculosis (Tb). Aprospective
clinical trialwas conducted to determine the diagnostic value of ADA activity in bronchoalveolar lavage (BAL) in sputum
smear-negative subjects highly suggestive for pulmonaryTb.Nineteen (M/F:15/4, mean age 46.8716.5 years) sputum
smear-negative patients highly suggestive for pulmonaryTb constituted Group I. Acid fast bacilli (AFB) grew on sputum
and/or BAL culture of all subjects in this group.Twenty-nine patients (M/F:19/10, mean age 55.778.0 years) with non-
tuberculouspulmonarydiseasesconstitutedGroup II.Tenofthemhadinterstitiallungdisease, ninelungcancer, fivepneu-
monia and five COPD.Twelve subjects (M/F: 7/5, mean age 48.4712.8 years) constituted the controls (Group III) under-
going fiberoptic bronchoscopy (FOB) for various indications and the lungswere found to be normal eventually. Albumin
and ADA activity levels were measured in plasma and BAL in all the subjects. LocalADAwas calculated. PlasmaADA and
BALADA of Group I was significantly higher (Po0.001) than that of the other groups. LocalADAwas also the highest in
Group Iwhen comparedwiththe others (Po0.001) butthatof Group IIwas also higher (Po0.01) when comparedwith
controls.With a cut-off value derived from the control subjects, sensitivity of BALADAwas100% and specificity 85.3%.
Sputum PCR results are available in a couple of dayswhereas thatof BALADA are available in a couple of hours andBA-
LADA costs cheaper than PCR in our country.Therefore, we conclude that BALADAmay be a useful, cheaper and faster
diagnostic testin sputumsmear-negativepatientshighly suggestive forpulmonaryTb.LocalADAneednotbe calculated as
it is also significantlyhigher in Group II subjects and thusnot as reliable as BALADA.r2002 Publishedby Elsevier Science Ltd
doi:10.1053/rmed.2001.1284, available online at http://www.idealibrary.comonINTRODUCTION
The diagnosis of pulmonary tuberculosis (Tb) is
established by detecting Mycobacterium tuberculosis on
the smear and culture of sputum, gastric lavage,
bronchial washings or lung tissue. Fiberoptic broncho-
scopy (FOB) is indicated in order to obtain bronchial
washings and/or lung tissue in patients who do not
produce sputum (1). In smear-negative patients, anti-tu-
berculous treatment is delayed until the culture results
are available. This costs the patient approximately
2 months, a very valuable time in which he or she
could have received the initial antituberculous treat-
ment. So, the patients not producing sputum or
sputum smear-negative ones are diagnostic challenges
to health professionals. Therefore, rapid and reliableReceived 20 July 2001, accepted in revised form 20 December 2001.
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of researchers recently. The diagnostic value of Tb
polymerase chain reaction (PCR) in sputum and
bronchial washings has already been established (2).This
procedure has considerably shortened the time
(24^48h) for the identi¢cation of mycobacteria, in
comparison with the time required by microbiological
tests. However, it is still an expensive procedure in
Turkey.
ADA is an enzyme present in the purine metabolism.
It catalyzes the irreversible deamination of deoxyadeno-
sine and adenosine to deoxyinosine and inosine, respec-
tively, and plays an important role in lymphocyte
and monocyte maturation and activity. There are three
molecular forms of ADA, namely, ADA1, ADA1+cp and
ADA2. Normal serum contains ADA1+cp and ADA2.
ADA1 is found in the tissue and ADA2 is unique to
monocyte/macrophage cell lineage (3). CD4+ lympho-
cytes and macrophages may account for the increase in
ADA activity (4).
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£uids of patients withTb, like sera, pleural, pericardial,
peritoneal or cerebrospinal e¡usions. Hence, detecting
ADA activity in blood, pleural e¡usion, ascitic £uid
or bronchoalveolar lavage (BAL) may serve as a rapid
diagnostic test replacing the time requiring culture
methods.
A prospective clinical trial was conducted to evaluate
the diagnostic value of total ADA activity in BAL of spu-
tum smear-negative patients with a presumptive diagno-
sis of pulmonaryTb.
MATERIALSANDMETHODS
Sixty subjects participated in the study.They constituted
three groups according to the ¢nal diagnosis:
Group I consisted of 19 (M/F: 15/4, mean age
46.8716.5 years, range: 18^78) sputum smear-negative
patients with pulmonaryTb. Sputum and/or BAL culture
for acid-fast bacilli (AFB) was positive.
Group II consisted of 29 (M/F: 19/10, mean age
55.778.0 years, range: 39^70) patients with non-tuber-
culous pulmonary diseases: 10 interstitial lung disease,
nine lung cancer, ¢ve pneumonia and ¢ve COPD.
Group III consisted of 12 (M/F: 7/5, mean age
48.4712.8 years, range: 18-68) control subjects under-
going ¢beroptic bronchoscopy (FOB) for variousreasons
and no pathologic ¢ndings could be reached eventually.
None of the sputum or BAL of subjects of Groups II and
III grew AFB on culture.
Oral consent was obtained from all subjects under-
going FOB. After one night of starvation, premedication
with atropin 1/4mg s.c. was done and local anesthesia
was applied by nebulising 2% prylocain. An Olympus
FOB (type P20D or 1T20D, Tokyo, Japan) was inserted
transorally and BAL was performed on the most af-
fected segment in Group I subjects and on the middle
lobe or lingula in subjects with miliary radiological pat-
tern or non-Tb lung disease and the controls. Five ali-
quots of 20ml of normal saline solution at room
temperature were instilled and immediately retrieved
with a hand-held syringe. After ¢ltering the recovered
BAL through three layers of gauze, an aliquot was sent
for AFB smear and culture. After centrifuging the re-
maining at 400 g, the supernatant was stored at 201C
until it was analyzed for albumin (BALAlbumin) and ADA
(BALADA) activity.
Simultaneously,10ml of venous bloodwas drawn from
every subject. It was centrifuged and the plasma was
stored at 201C until albumin level (PlasmaAlbumin) and
ADA (PlasmaADA) activity weremeasured.
ADA assay was carried out according to the colori-
metric method of Guisti in which ammonia released by
the hydrolysis of adenosine to inosine is measured with
Berthelot’s reaction. ADA activity was expressed as IU/L. Absorbencies were read by using a Unicam Henios &
UV-VIS spectrophotometer (Unicam Ltd., Cambridge,
U.K.) (5).
Albumin was measured by nephelometry by a com-
mercial KIT (DADE Behring,Germany).
LocalADAwas worked out using the following formula
derived by using two assumptions (6):
1. ADA found in BAL should be equal to locally
produced ADA (Local ADA) plus the di¡used ADA
(Di¡usedADA).Thus;
K LocalADA=BALADADi¡usedADA.
2. Assuming that albumin is not produced in the lungs
but di¡uses from the vascular space;
K BALAlbumin = Di¡usedAlbumin = PlasmaAlbumin.
With these two assumptions we calculated the Dif-
fused ADA as follows and placed it in the above formula:
K Di¡usedADA = PlasmaADA
K Di¡usedADA/BALAlbumin = PlasmaADA/PlasmaAlbumin
K Di¡usedADA = PlasmaADA  BALAlbumin/
PlasmaAlbumin
K LocalADA = BALADA - (PlasmaADA  BALAlbumin/
PlasmaAlbumin)
Statistics: Statistical analysis was carried out on a PC
using SPSS program version 4.0. Results were expressed
asmean7 SD.Groupswere comparedwithMann^Whit-
ney U, Kruskal^Wallis One-Way ANOVA and Chi-
Square tests.
RESULTS
Three groups were comparable with respect to gender,
age and smoking habits. Characteristics of the subjects
can be seen inTable1.
All patients with pulmonaryTb had a negative sputum
smear for AFB. Fifteen of them grew AFB on L˛wen-
stein^Jensen. BAL smear of two of these subjects were
positive and 17 of them negative for AFB, whereas 13 of
them grewAFB on culturemedia. AFBwas grown either
on sputum or BAL of patients in Group I. Sputum and
BAL smear and culture results for AFB of Group I are
shown inTable 2.
Group II subjects had various non-tuberculous pul-
monary diseases. Ten of them had interstitial lung dis-
ease, nine lung cancer, ¢ve pneumonia and ¢ve COPD.
InTable 3 a detailed list of the de¢nite diagnosis of Group
II patients can be seen.
The amount of retrieved BAL was signi¢cantly higher
in control subjects (Table 4).
TABLE 1. Characteristics of the study subjects
M:F Age
(range)
No. of smokers
(%)
Pack-years
(range)
Group I
PulmonaryTb
n= 19
15:4 46.8716.5 (18^78) 11 (57.9%) 51.8718.7 (30^70)
Group II
Non-Tb lungdis.
n= 29
19:10 55.778.0 (39^70) 19 (65.5%) 54.4725.3 (20^100)
Group III
Control
n= 13
7:5 48.4712.8 (18^68) 5 (41.7%) 43.0713.0 (30^70)
TABLE 2. Smear and culture results of prebronchoscopic sputumand BALof Group I for AFB
AFB Smear () Smear (+) Culture () Culture (+)
Prebronchoscopic sputum 19 0 4 15
Bronchoalveolar lavage 17 2 6 13
TABLE 3. De¢nite diagnosis of Group IIpatients
Non-Tb pulmonarydiseases De¢nite diagnosis n =29
Interstitial lungdisease (n = 10) Romatoid artrit + pulmonaryinvolvement 2
Scleroderma + pulmonary involvement 2
Idiopathic pulmonary ¢brosis 3
Pneumoconiosis 2
Extrinsic allergic alveolitis 1
Lungcancer (n = 9) Small cell lungcancer 1
Nonsmall cell lungcancer 7
Breastcancer + lungmetastasis 1
Pneumonia 5
COPD 5
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are shown. PlasmaAlbumin level did not show any di¡er-
ence between the study groups. BALAlbumin in Group I
was signi¢cantly higher than that of Groups II and III.
PlasmaADA and BALADA were signi¢cantly higher
in Group I when compared with the other groups. Simi-
larly, LocalADA was the highest in Group I when com-
pared with the other two groups, whereas that of
Group II was also signi¢cantly higher than that of Group
III (Table 4).
The cut-o¡ values were determined using the mean
values +2 SD of the control group. Using these cut-o¡
values sensitivity, speci¢city, positive and negative
predictive values (PPV and NPV, respectively) of
PlasmaADA, BALAlbumin, BALADA and LocalADAwere de-termined.The sensitivity of BALADA and LocalADAwere
100%. Although the speci¢city of Plasma ADAwas higher
than that of BALADA and LocalADA, its sensitivity, PPV
and NPV were low.We also determined second cut-o¡
values using the results of Group II. According to the
new cut-o¡ values, the sensitivity and NPV of BALADA
and LocalADA decreased considerably, whereas speci¢-
city and PPV increased. Sensitivity, speci¢city, PPV and
NPV of PlasmaADA, BALAlbumin, BALADA and LocalADA
according to both cut-o¡ values are shown inTable 5.
BALADAwas signi¢cantly higher in patientswith active
pulmonaryTb when compared to patients with non-Tb
lung diseases and controls (Po0.001). Most of the pa-
tients’ BALADA inTb groupwere above the cut-o¡ levels
(Fig.1).
TABLE 4. Retrieved BAL,PlasmaAlbumin,PlasmaADA,BALAlbumin,BALADA and LocalADAofthe study subjects
GROUP IpulmonaryTb GROUP IInon-Tb lungdis. GROUP III control
Retrieved BAL (mL) 36.8711.9 * 42.8712.0 49.2711.6
Plasma
AlbumyŁ n
(g/L) 24.47 6.2 26.675.5 28.475.4
Plasma
ADA
(U/L) 34.4714.0w 14.87 6.8 16.775.9
BAL
Albumin
(mg/L) 63.67 44z 25.4735.8 41.8778.0
BAL
ADA
(U/L) 3.172.0w 0.47 0.5 0.270.4
Local
ADA
(U/L) 2.9972.05w 0.447 0.54} 0.1170.26
*Po0.01when comparedwith Group III
wPo0.001when comparedwith Groups II and III.
zPo0.001ando0.05 when comparedwith Groups II and IIIrespectively.
}Po0.01when comparedwith Group III.
TABLE 5. Sensitivity, speci¢city, positive and negative predictive values of PlasmaADA,BALADA and LocalADA determined by
using the cut-o¡ value obtained by the results of the controlgroup
Cut-o¡ values (U/l) Sensitivity (%) Speci¢city (%) Positive predictive value (%) Negative predictive value (%)
PlasmaADA 28.5 (28.4) 52.6 (52.6) 92.6 (92.6) 76.9 (76.9) 80.8 (80.8)
BALADA 1 (1.4) 100 (84.2) 85.3 (95) 76 (88.8) 100 (90.6)
LocalADA 0.63 (1.54) 100 (73.6) 82.9 (95) 70.3 (87) 100 (90.6)
Note: In brackets the same values determined by using cut-o¡ value are obtained by the results of non-tuberculosis lung dis-
ease patients
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FIG. 1. BALADA of all subjects in Group Iwere higher than the
cut-o¡ value determinedby themean+2 SD ofthe controlgroup
(1U/L).Only a few subjects had lower values than the cut-o¡ va-
lue ofthe non-tuberculous lungdisease group (1.4 U/L).
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We studied 60 subjects to determine the diagnostic value
of ADA activity in bronchoalveolar lavage (BAL) in spu-
tum smear-negative subjects highly suggestive for pul-
monaryTb.The study subjects constituted three groups
according to the ¢nal diagnosis: 19 sputum smear-nega-
tive patients with pulmonaryTb (Group I), 29 with non-
tuberculous pulmonarydiseases (Group II) and12 healthycontrol subjects (Group III).Groups II and III were nega-
tive for AFB on sputum or BAL culture.BALADAwas sig-
ni¢cantly higher in patients with active pulmonary Tb
when compared to patients with non-Tb lung diseases
and controls (Po0.001). In agreementwith previous ¢nd-
ings (6), we found high sensitivity (100%) and speci¢city
(%85.3) for BALADA.
To establish the diagnosis of pulmonaryTb,M. tubercu-
losis should be detected in sputum smears and/or grown
in (L˛wenstein^Jensen) culture media. Rapid diagnostic
tests are needed to replace these time-requiring meth-
ods delaying the commencement of treatment.
The ADA activity in ascitic, pleural, pericardial or cer-
ebrospinal £uidshasbeen studied.Diagnostic accuracyof
ADA activity of the ascitic £uid is reported to be very
high by some authors (7^9); however, some do not con-
¢rm this ¢nding (10).
ADA activity of the pleural £uid has also been studied
world-wide.Con£icting results havebeen reported from
countrieswith high or low prevalence of Tb (11). Authors
from high prevalence countries (9,12^14) have reported
high sensitivity, speci¢city and diagnostic value for ADA
activity in the diagnosis of tuberculous pleural e¡usions.
It is suggested that higher values of ADA activity could
be detected in pleural e¡usions driven by repeated thor-
acenthesis (15). It is concluded that ADA could serve as a
marker amongstothers in the di¡erential diagnosis of tu-
berculous and malignant pleural e¡usions (16). On the
contrary, ADA activity in pleural e¡usions was found to
540 RESPIRATORYMEDICINEbe non-diagnostic, in a low prevalence country for Tb
(17).
A few authors have studied ADA activity in BAL. Ku-
bota (18,19) and Albera et al. (4) havemeasured ADA ac-
tivity in BAL in patients with sarcoidosis and pulmonary
Tb. ADA activity was increased in BAL from patients
with sarcoidosis as well as Tb, as a result of activation,
di¡erentiation and proliferation of blood-derivedmono-
nuclear cells. Although ADA activity of BAL from sarcoi-
dosis patients was signi¢cantly higher than that of
normal controls, it was still lower than that of Tb pa-
tients.The authors have suggested that ADA activity of
BAL could be a marker of activation in sarcoidosis (4,19)
and a very sensitive diagnostic tool in six cases of miliary
Tb (18).
Both Albera (4) and Pushpakom et al. (20) have ob-
served a positive correlation with BAL ADA activity
and activated T cells suggesting that these cells were re-
sponsible for the elevation of ADA activity in BAL.
Orphanidou et al. (6) have studied 76 patientswithvar-
ious lung diseases including Tb. They detected a signi¢-
cant increase of ADA activity in BAL of patients withTb
when compared with that of patients with non-Tb lung
diseases. In the present study, we also detected an in-
crease in ADA activity in BAL with the same level of sig-
ni¢cance inTb patients when compared with those with
non-Tb lung disease and normal controls. On the con-
trary, the plasma ADA activity of their study subjects
didnotdi¡er signi¢cantly,whereas thatof theTbpatients
in the present study was signi¢cantly higher than the
other two study groups.
ERS Task Force has recommended to instil 240ml of
normal saline in BAL procedure (21). However, as we
had started the studybefore this statementhadbeen re-
ported, we used 100ml and did not change the amount
throughout the study for the sake of homogenity.
The retrieved BAL amountwas the lowest in subjects
with pulmonary Tb and the di¡erence was signi¢cant
when compared with controls, whereas the retrieved
BAL amount did not di¡er between non-Tb pulmonary
disease group and the controls. In pulmonaryTb group,
BAL was performed on the most a¡ected sites namely,
the upper lobs or apical segment of the lower lobs.This
accounts for the lower amount of retrieved BAL when
comparedwith the other groups, inwhomBALwasper-
formed on the middle lob or lingula where a better
amount of BAL can be retrieved.
BALADA and LocalADA were the highest in Tb group
with statistically signi¢cant di¡erence compared with
the other two groups. BALADA in the non-Tb lung dis-
ease and control groups did not di¡er from each other,
however, LocalADA showed a slight but signi¢cant in-
crease in non-Tb lung disease group when compared
with controls.
BALADA has a high sensitivity and negative predictive
value similar to those of LocalADA and a higher speci¢cityand positive predictive value than LocalADA has.We con-
clude that BALADA could be a more reliable parameter
than LocalADA in establishing the diagnosis of pulmonary
Tb even if lower than previously reported (6) cut-o¡ va-
lues were used. In agreement with the ERS Task Group
recommendations (21), BALADA should be expressed as
U/L providing the instilled and retrieved BAL volumes.
This can save time and money, by avoiding BALalbumin
and Plasmaalbumin measurements and LocalADA calcula-
tion using complicated formulas.
To the best of our knowledge, this is the ¢rst report
with BALADA measurement in a control group besides
non-Tb lung disease group. For this reason, two cut-o¡
values were derived from the BALADA of controls and
non-Tb lung disease group.
M. tuberculosis PCR in bronchial aspirates is a rapid di-
agnostic procedure with a high sensitivity (B95%) and
speci¢city (B70%)in sputum smear-negative pulmonary
Tb patients (22^25). In a study conducted in Kenya (26),
smearmicroscopy was found1.8 time as cost-e¡ective as
PCR.The authors have concluded that, in case the cost
of the PCR-kitcouldbereduced substantially,PCRmeth-
od could potentially be used for screening procedure for
Tb. In the present study, bronchoscopy and BALADA
measurement have costed 80$ (USD) per patient
whereas sputum PCR test costs 113$ (USD) per patient.
Besides the higher cost PCR results are available in 24^
48hwhereas that of BALADA are available in a couple of
hours.Thus, although it is an invasiveprocedure, BALADA
seems to be a more cost-e¡ective diagnostic procedure
than PCR test, in our country.
BALADA is signi¢cantly higher in patients with active
pulmonaryTb when compared to patients with non-Tb
lungdiseases and controls.With its high sensitivity, speci-
¢city, positive and negative predictive values, it may
serve as a rapid diagnostic tool. Thus, anti-tuberculous
treatment can be startedwithout any delay.
Althoughwe studied a limited number of smear-nega-
tive subjects, we found high sensitivity rates.We there-
fore believe that BALADA activity may serve as a rapid
diagnostic tool for the commencement of antitubercu-
lous treatment without any delay until the sputum and/
or BAL culture results are obtained. However, further
studies in large series of such patients are needed to es-
tablish the diagnostic value of the test.
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